Company / Cash per Share
Viking Therapeutics, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.49
FY2025
5-year range
$0.27 / $1.49
FY2021-FY2025
Trend
+457.7%
vs FY2024
Sector context
#127 of 205
Health Care
What the data says
Cash per Share changed +458% YoY in FY2025, a notable deviation from the 9-year average annual change of +118%.
Based on SEC 10-K filings.
1.49 in FY2025 with a 5-year CAGR of +29.9%.
Improved from $0.71 to $1.49 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +47.0%
- 5-Year CAGR
- +29.9%
- 10-Year CAGR
- -
Sector benchmark
#127 of 205 in Health CareTop 62% of 205This company $1.49 Sector average $72.93
▼
-98.0% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 457.7% year-over-year.
- Ranks #127 out of 205 companies in the Health Care sector.
- Lowest cash per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.49 | +457.7% |
| FY2024 | $0.27 | -62.4% |
| FY2023 | $0.71 | +51.5% |
| FY2022 | $0.47 | +30.0% |
| FY2021 | $0.36 | -10.4% |
| FY2020 | $0.40 | +244.4% |
| FY2019 | $0.12 | -53.5% |
| FY2018 | $0.25 | -41.9% |
| FY2017 | $0.43 | +443.8% |
| FY2016 | $0.08 | -37.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026